Publications

Achieving validation of elimination of mother-to-child transmission (EMTCT) of HIV, syphilis and hepatitis B virus (HBV) is a tremendous accomplishment, requiring health ministry–led accountability, rigorous data analysis, intensive programme assessment and multilevel collaboration. This governance guidance outlines the standardized structures and processes used to validate EMTCT of HIV, syphilis and HBV at the national, regional and global levels. Replacing an earlier version published in June 2020 addressing EMTCT of HIV and syphilis, this revised governance document aligns with new information in the Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis, and hepatitis B virus, in which WHO sets criteria for validation of triple elimination.

A series of country pilots (Brazil, Egypt, Georgia, Mongolia, Rwanda, Thailand and United Kingdom of Great Britain and Northern Ireland) of the elimination criteria across the six WHO regions was undertaken during 2021–2022. The main objective was to conduct a practical assessment and evaluate the feasibility of accurately measuring the impact and programmatic targets for hepatitis elimination as established by the WHO Interim guidance for country validation of viral hepatitis elimination.

This policy brief focuses on the new recommendations on treatment of adolescents and children aged 3 years or older with chronic hepatitis C virus (HCV) infection.

This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and task-sharing, in addition to the use of point-of-care (POC) HCV viral load assays and reflex viral load testing. 

The 2022 Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response to HIV, viral hepatitis and sexually transmitted infections (STIs) for 5 key populations (men who have sex with men, sex workers, people in prisons and other closed settings, people who inject drugs and trans and gender diverse people). The guidelines present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines which are summarised here in this policy brief.

This guide aims to help advance progress on the path to HIV epidemic control by providing HIV service providers with a practical framework to direct and advance the evolution of evidencebased, client-centered strategies to minimize the HIV risks associated with sexualized drug use, particularly among men who have sex with men (MSM). 

This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration on HIV and AIDS, which the United Nations General Assembly adopted in June 2021 and they are underpinned by the Global AIDS Strategy (2021–2026). The Strategy sets out the principles, approaches, priority action area and programmatic targets for the global HIV response.

An end to AIDS in children, achieved through a strong, strategic, and action-oriented alliance of multisectoral stakeholders at national, regional, and global levels that works with women children and adolescents living with HIV, national governments, and partners to mobilize leadership, funding, and action to end AIDS in children by 2030.

This brief provides guidance for countries developing and implementing comprehensive virtual intervention services. It is complementary to a more detailed guide on planning and budgeting.

The new strategies propose a common vision to end epidemics and advance universal health coverage, primary health care and health security in a world where all people have access to high-quality, evidence-based and people-centred health services. The GHSS promote the disease-specific goals to end AIDS and the epidemics of viral hepatitis and sexually transmitted infections by 2030, with 5 strategic directions providing the overall guiding framework for achieving these goals.